March 2017 - Volume 72 - Issue 3 - Contributor Index

Author:
Ghezzi, Fabio

Is Mirabegron Equally as Effective When Used as First- or Second-Line Therapy in Women With Overactive Bladder?

Serati, Maurizio; Roberti Maggiore, Umberto Leone; Sorice, Paola; More

Obstetrical & Gynecological Survey . 72(3):160-161, March 2017.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Fowler, Mary G.; Qin, Min; Fiscus, Susan A.; More

Obstetrical & Gynecological Survey . 72(3):143-145, March 2017.

Author:
Gokçü, Mehmet

Vaginal Progesterone as Maintenance Treatment After an Episode of Preterm Labour (PROMISE) Study: A Multicentre, Double-blind, Randomised, Placebo-Controlled Trial

Palacio, Montse; Cobo, Teresa; Antolín, Eugenia; More

Obstetrical & Gynecological Survey . 72(3):151-153, March 2017.

International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: Prospective Cohort Study...

Papageorghiou, Aris T.; Ohuma, Eric O.; Gravett, Michael G.; More

Obstetrical & Gynecological Survey . 72(3):141-143, March 2017.

Low-Molecular-Weight Heparin and Recurrent Placenta-Mediated Pregnancy Complications: A Meta-analysis of Individual Patient Data From Randomised Controlled Trials

Rodger, Marc A.; Gris, Jean-Christophe; de Vries, Johanna I. P.; More

Obstetrical & Gynecological Survey . 72(3):153-155, March 2017.